346 related articles for article (PubMed ID: 16966324)
1. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation.
Wrighton KH; Liang M; Bryan B; Luo K; Liu M; Feng XH; Lin X
J Biol Chem; 2007 Mar; 282(9):6517-24. PubMed ID: 17202138
[TBL] [Abstract][Full Text] [Related]
3. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
[TBL] [Abstract][Full Text] [Related]
4. TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.
Ikeuchi Y; Dadakhujaev S; Chandhoke AS; Huynh MA; Oldenborg A; Ikeuchi M; Deng L; Bennett EJ; Harper JW; Bonni A; Bonni S
J Biol Chem; 2014 Sep; 289(36):25067-78. PubMed ID: 25059663
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
6. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
7. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
8. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
9. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
10. Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.
Netherton SJ; Bonni S
PLoS One; 2010 Nov; 5(11):e13971. PubMed ID: 21103059
[TBL] [Abstract][Full Text] [Related]
11. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
12. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
13. Modification of the erythroid transcription factor GATA-1 by SUMO-1.
Collavin L; Gostissa M; Avolio F; Secco P; Ronchi A; Santoro C; Del Sal G
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8870-5. PubMed ID: 15173587
[TBL] [Abstract][Full Text] [Related]
14. PIAS1 interacts with and represses SOX9 transactivation activity.
Oh HJ; Kido T; Lau YF
Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription.
Tiefenbach J; Novac N; Ducasse M; Eck M; Melchior F; Heinzel T
Mol Biol Cell; 2006 Apr; 17(4):1643-51. PubMed ID: 16421255
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of Blimp-1 is critical for plasma cell differentiation.
Ying HY; Su ST; Hsu PH; Chang CC; Lin IY; Tseng YH; Tsai MD; Shih HM; Lin KI
EMBO Rep; 2012 Jun; 13(7):631-7. PubMed ID: 22555612
[TBL] [Abstract][Full Text] [Related]
18. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
19. SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.
Liu S; Long J; Yuan B; Zheng M; Xiao M; Xu J; Lin X; Feng XH
J Biol Chem; 2016 Nov; 291(47):24418-24430. PubMed ID: 27703003
[TBL] [Abstract][Full Text] [Related]
20. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
